Spotlight on Hepatitis B: New report examines the disease’s clinical trial landscape in 2025
Hepatitis B is a highly infectious liver disease caused by the Hepatitis B virus (HBV) and is primarily transmitted through…
All articles by Nikki Thompson
Nikki Thompson
-
-
How will AI shape the future of the NHS?
The UK government’s latest initiative to revolutionise healthcare through technology and artificial intelligence (AI) signals a shift towards a more…
-
COVID-19: The global clinical trial landscape in 2024
COVID-19, caused by the SARS-CoV-2 virus, has profoundly reshaped global healthcare since its emergence in December 2019. By 2024, the…
-
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
Petrovax has announced encouraging findings from the Long-CoV-III-21 trial, a randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of…
-
Transforming preventative care in the NHS
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the…
-
The growing role of CDMOs in the circular economy
Sustainability in the 21st century is an essential component of business operations. With regard to environmental stewardship, new regulations in…
-
Healing begins with research: Promising development program on stem cells in rare diseases
Despite their potential to revolutionise medicine, stem cell therapies have long faced scepticism within the pharmaceutical industry. Concerns about the…
-
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication
On-dose authentication, the practice of integrating traceable markers directly into or onto pharmaceutical products, is yet to be implemented within…
-
Pioneering ePRO and eCOA innovations for next-generation clinical trials
The pharmaceutical industry is undergoing a major transformation, as clinical trials become increasingly data heavy and digital-based. Traditional methods of…
-
Combating Pharmaceutical Crime with On-Dose Authentication
Despite the best efforts of pharmaceutical manufacturers and regulators to improve the security and traceability of drug products, counterfeits continue…